期刊文献+

多柔比星壳聚糖纳米粒的制备及其体外评价 被引量:1

Preparation and in vitro release of Chitosan nanoparticles containing Doxorubicin
原文传递
导出
摘要 目的制备多柔比星壳聚糖纳米粒,并研究其包封情况和控释能力。方法采用离子交联法制备多柔比星壳聚糖纳米粒,激光粒度仪测定粒径的分布,HPLC法测定纳米粒的包封率,透析法测定多柔比星壳聚糖纳米粒的体外释放情况。结果壳聚糖的浓度增加,纳米粒的粒径增加、包封多柔比星的效率也增加;壳聚糖溶液的pH增加,纳米粒的粒径降低而包封多柔比星的效率增加;壳聚糖分子量增加对多柔比星的包封效率影响较小,但粒径增加,多柔比星突释减小,释放速率降低。结论多柔比星可以通过离子交联法制备壳聚糖纳米粒,其粒径、包封率可控,具有缓释效果。 OBJECTIVE To prepare Chitosan nanoparticles containing Doxorubicin ( CS - DOX - NPs) and investigate the characteristics of encapsulation efficiency (EE) and in vitro release. METHODS CS - DOX - NPs were prepared by ionic gelation process. The distribution of particle size of the NPs was determined by Malvern particle size analyzer. The EE was examined by HPLC method. The in vitro release was investigated by dialysis. RESULTS The particle size and EE of chitosan nanoparticles both increased with increased chitosan concentration. With increasing pH value of chitosan solution, the EE increased and the particle size decreased. The molecular weight had little effect on the encapsulation efficiency, but the in vitro release rate decreased with increasing molecular weight of chitosan. CONCLUSION CS - DOX - NPs prepared by ionic gelation method exhibited sustained release in vitro and the particle size and EE were controllable.
机构地区 南京中医药大学
出处 《华西药学杂志》 CAS CSCD 北大核心 2009年第6期612-614,共3页 West China Journal of Pharmaceutical Sciences
关键词 多柔比星 壳聚糖 三聚磷酸钠 纳米粒 Doxorubicin Chitosan Sodium tripolyphosphate Nanoparticle
  • 相关文献

参考文献6

  • 1Bilati U, Allemann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles[J]. Eur J Pharm Sci,2005,24( 1 ) :67 -75.
  • 2Liu J, Gong T, Wang C, et al. Solid lipid nanoparticles loaded with insulin by sodium cholate - phosphatidylcholine - based mixed micelles : preparation and characterization [ J ]. Int J Pharm,2007, 340(1) :153 - 162.
  • 3Chen F, Zhang ZR, Huang Y. Evaluation and modification of N - trimethyl chitosan chloride nanoparticles as protein carriers [ J]. Int J Pharm, 2007,336(1) : 166 -173.
  • 4Jain S, Sharma RK, Vyas SP. Chitosan nanoparticles encapsulated vesicular systems for oral immunization : preparation, in vitro and in vivo characterization [ J ]. J Pharm Pharmacol, 2006,58 ( 3 ) : 303 - 310.
  • 5Papagiannaros A, Hatziantoniou S, Dimas K,et al. A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC) :physico - chemical characterization and cytotoxic activity against human cancer cell lines [ J]. Biomed Pharmacother, 2006,60( 1 ) :36 -42.
  • 6Wang CH, Wang CH, Hsiue GH. Polymeric micelles with a pH- responsive structure as intracellular drug carriers [ J ]. J Contr Releas,2005,108 ( 1 ) : 140 - 149.

同被引文献6

  • 1林爱华,刘奕明,平其能.壳聚糖纳米粒表面游离氨基与纳米粒特性研究[J].药学学报,2007,42(3):323-328. 被引量:24
  • 2KURDOW R,SCHNIEWIND B,ZOEFELT S,et al.Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression[J].Langenbecks Arch Surg.2005,390(3):243-248.
  • 3YARDLEY DA.Gemcitabine and docetaxel in metastatic and neoadjuvant treatment of breast cancer[J].Semin Oncol,2004,31(2 Suppl 5):37-44.
  • 4FAN Z,JINGHUA M,DI Z,et al.Gemcitabine and oxaliplatin combination chemotherapy in 30 patients with advanced pancreatic carcinoma [J].Chin Ger J Clin Oncol.2007,6(5):461-463.
  • 5AGNIHOTRI SA,MALLIKARJUNA NN,AMINABHAVI TM.Recent advances on chitosan based micro and nanoparticles in drug delivery[J].J Control Release.2004,100(1):5-28.
  • 6张宏亮,邬思辉,臧林泉,苏政权.抗肿瘤药物壳聚糖载体的研究进展[J].现代生物医学进展,2009,9(3):574-576. 被引量:6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部